BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29261154)

  • 1. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
    Ungefroren H; Witte D; Fiedler C; Gädeken T; Kaufmann R; Lehnert H; Gieseler F; Rauch BH
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
    Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer.
    Witte D; Zeeh F; Gädeken T; Gieseler F; Rauch BH; Settmacher U; Kaufmann R; Lehnert H; Ungefroren H
    J Clin Med; 2016 Nov; 5(12):. PubMed ID: 27916875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
    Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
    Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer.
    Ungefroren H; Reimann J; Konukiewitz B; Braun R; Wellner UF; Lehnert H; Marquardt JU
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced biosensors for nanomaterial-based detection of transforming growth factor alpha and beta, a class of major polypeptide regulators.
    Gaba S; Jain U
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128622. PubMed ID: 38065462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer.
    Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G
    Bioorg Chem; 2024 May; 150():107496. PubMed ID: 38850590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors.
    Arai M; Hanada M; Moriyama H; Ohmoto H; Miyake T; Naka K; Sawa M
    Bioorg Med Chem Lett; 2024 Aug; 108():129797. PubMed ID: 38759932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mysteries of TGF-β Paradox in Benign and Malignant Cells.
    Zhang Q; Yu N; Lee C
    Front Oncol; 2014; 4():94. PubMed ID: 24860782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAR2 biased signaling on the move.
    Nieman MT
    Blood; 2024 Mar; 143(10):835-836. PubMed ID: 38451512
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction: The PAR2 signal peptide prevents premature receptor cleavage and activation.
    Liu B; Lee G; Wu J; Deming J; Kuei C; Harrington A; Wang L; Towne J; Lovenberg T; Liu C; Sun S
    PLoS One; 2024; 19(6):e0305363. PubMed ID: 38843168
    [No Abstract]   [Full Text] [Related]  

  • 12. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
    Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
    J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis.
    Bäcker V; Cheung FY; Siveke JT; Fandrey J; Winning S
    PLoS One; 2017; 12(12):e0190074. PubMed ID: 29261815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection.
    Latella G
    Dig Dis Sci; 2018 Feb; 63(2):312-320. PubMed ID: 29273848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mapping of DNA regions required for SV40 early region promoter function in vivo.
    Fromm M; Berg P
    J Mol Appl Genet; 1982; 1(5):457-81. PubMed ID: 6296253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.
    Searles G; McKendry RJ
    J Rheumatol; 1987 Dec; 14(6):1164-71. PubMed ID: 3325643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR.
    Jiang Y; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
    Br J Pharmacol; 2021 Feb; 178(4):913-932. PubMed ID: 33226635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
    Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation.
    Ungefroren H; Konukiewitz B; Braun R; Wellner UF; Lehnert H; Marquardt JU
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.